Clinical trials: immunohistochemistry staining method, completed
Recurrent Melanoma, Stage IV Melanoma
Vaccine Therapy Following Therapeutic Autologous Lymphocytes and Cyclophosphamide in Treating Patients With Metastatic Melanoma
This phase I trial studies the side effects and best dose of autologous T-antigen-presenting cells (T-APC) vaccine following therapeutic autologous lymphocytes (CTL) and cyclophosphamide in treating patients with metastatic…
- Trial name
- NCT01339663
- Testing
- cyclophosphamide, aldesleukin, autologous tumor cell vaccine
- Where
- United States
- Volunteers
- 12 people
- Sponsor
- Fred Hutchinson Cancer Center
Chronic Myeloproliferative Disorders, Leukemia
Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant
RATIONALE: Studying immune response to flu vaccine in patients who have undergone a stem cell transplant may help doctors plan the best treatment.
- Conditions
- Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm
- Trial name
- NCT00964821
- Testing
- trivalent influenza vaccine, Immunoenzyme technique, Laboratory biomarker analysis
- Where
- 2 sites in United States
- Volunteers
- 459 people, healthy volunteers welcome
- Sponsor
- City of Hope Medical Center
Multiple Myeloma, Plasma Cell Neoplasm
Biomarkers Related to Thrombosis in Patients With Newly Diagnosed Multiple Myeloma Receiving Chemotherapy
RATIONALE: Studying samples of blood in the laboratory from patients receiving chemotherapy may help doctors learn more about the effects of chemotherapy on cells.
- Conditions
- Multiple Myeloma, Plasma Cell Neoplasm, Thromboembolism
- Trial name
- NCT01132833
- Testing
- enzyme-linked immunosorbent assay, laboratory biomarker analysis, medical chart review
- Where
- United States
- Volunteers
- 18 people
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
Recurrent Melanoma, Stage IV Melanoma
Laboratory-Treated T Cells and Ipilimumab in Treating Patients With Metastatic Melanoma
This phase I/II trial is studying the side effects of giving laboratory-treated T cells and ipilimumab together to see how well they work in treating patients with metastatic melanoma.
- Trial name
- NCT00871481
- Testing
- ipilimumab, cyclophosphamide, biopsy
- Where
- United States
- Volunteers
- 10 people
- Sponsor
- Fred Hutchinson Cancer Center
Non Small Cell Lung Cancer
Study of the Expression of Met Receptor Fragments in Non Small Cell Lung Cancers
Our project, established through collaboration between clinicians (Oscar Lambret Center-University Hospital) and scientists (IBL), aims to evaluate the expression of Met fragments in the lung cancer (LC).
- Trial name
- MetLung (NCT01647867)
- Testing
- Met analysis on tissue and blood
- Where
- 2 sites in France
- Volunteers
- 56 people
- Sponsor
- Centre Oscar Lambret
Lung Cancer
Early Detection of Second Lung Cancer in Patients With Stage I Non-small Cell Lung Cancer
RATIONALE: Using new methods to examine sputum samples for the presence of cancer cells may detect lung cancer earlier. PURPOSE: Screening trial to study the effectiveness of new methods of examining sputum samples to detect…
- Trial name
- NCT00002667
- Testing
- cytology specimen collection procedure, immunoenzyme technique, study of high risk factors
- Where
- 5 sites in United States
- Volunteers
- 1,100 people
- Sponsor
- Eastern Cooperative Oncology Group
Biliary Tract Cancer, Cholangiocarcinoma
Biomarker Discovery in Patients With Advanced Biliary Tract Cancer
Biliary tract cancer is a rare gastrointestinal malignant neoplasm and includes intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, and gall bladder cancer.
- Conditions
- Biliary Tract Cancer, Cholangiocarcinoma, Gallbladder Cancer
- Trial name
- NCT04871321
- Testing
- nab-paclitaxel plus gemcitabine-cisplatin
- Where
- South Korea
- Volunteers
- 119 people
- Sponsor
- CHA University
Soft Tissue Sarcoma
Biomarker Differences in Samples From Patients With Undifferentiated Sarcomas
This clinical trial studies biomarker differences in samples from patients with undifferentiated sarcomas. Studying biomarker in tissue samples from patients with cancer in the laboratory may help doctors identify and learn more…
- Trial name
- NCT01802125
- Testing
- laboratory biomarker analysis
- Where
- United States
- Volunteers
- 49 people
- Sponsor
- Children's Oncology Group
Breast Cancer
Biomarkers in Tissue Samples From Patients With Breast Cancer Treated With Bevacizumab
RATIONALE: DNA analysis of tumor tissue may help doctors predict how well patients will respond to treatment. PURPOSE: This research study is studying biomarkers in tissue samples from patients with breast cancer treated with…
- Trial name
- NCT01156168
- Testing
- DNA analysis, gene expression analysis, polymorphism analysis
- Volunteers
- 363 people
- Sponsor
- ECOG-ACRIN Cancer Research Group
Testicular Germ Cell Tumor
Diagnostic Study of Patients With Stage I Testicular Cancer
RATIONALE: Diagnostic procedures may improve a doctor's ability to predict the recurrence of testicular cancer. PURPOSE: Diagnostic trial to detect the risk of recurrent disease in patients who have stage I testicular cancer and…
- Trial name
- NCT00003800
- Testing
- immunohistochemistry staining method, laboratory biomarker analysis, radionuclide imaging
- Where
- 12 sites in United States
- Volunteers
- 76 people
- Sponsor
- Eastern Cooperative Oncology Group
Precancerous Condition, Prostate Cancer
Study of Blood Samples From Older Patients at High Risk of Developing Prostate Cancer and From Healthy Male Participants
RATIONALE: Studying samples of blood in the laboratory from patients who are at high risk of developing prostate cancer may help doctors identify biomarkers related to cancer.
- Trial name
- NCT00898274
- Testing
- immunoenzyme technique, laboratory biomarker analysis
- Where
- 3 sites in United States
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Case Comprehensive Cancer Center